StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2022, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 21 Jan 2020 09:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögren's Syndrome http://www.streetinsider.com/Press+Releases/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html for the full story. http://www.streetinsider.com/Press+Releases/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Tue, 21 Jan 2020 09:00:00 -0400 A.06822034 A.25657929 WIZP WIZP WIZPD Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögren's Syndrome http://www.streetinsider.com/Press+Releases/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html for the full story. http://www.streetinsider.com/Press+Releases/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Tue, 21 Jan 2020 09:00:00 -0400 A.06822034 A.25657929 WIZP WIZP WIZPD Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögren's Syndrome http://www.streetinsider.com/Press+Releases/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html for the full story. http://www.streetinsider.com/Press+Releases/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Tue, 21 Jan 2020 09:00:00 -0400 A.06822034 A.25657929 WIZP WIZP WIZPD Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögren's Syndrome http://www.streetinsider.com/Press+Releases/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html for the full story. http://www.streetinsider.com/Press+Releases/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Tue, 21 Jan 2020 09:00:00 -0400 A.06822034 A.25657929 WIZP WIZP WIZPD Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögren's Syndrome http://www.streetinsider.com/Press+Releases/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html for the full story. http://www.streetinsider.com/Press+Releases/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Tue, 21 Jan 2020 09:00:00 -0400 A.06822034 A.25657929 WIZP WIZP WIZPD Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögren's Syndrome http://www.streetinsider.com/PRNewswire/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html for the full story. http://www.streetinsider.com/PRNewswire/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Tue, 21 Jan 2020 09:00:00 -0400 A.06822034 A.25657929 WIZP WIZP WIZPD Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögren's Syndrome http://www.streetinsider.com/PRNewswire/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html for the full story. http://www.streetinsider.com/PRNewswire/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Tue, 21 Jan 2020 09:00:00 -0400 A.06822034 A.25657929 WIZP WIZP WIZPD Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögren's Syndrome http://www.streetinsider.com/PRNewswire/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html for the full story. http://www.streetinsider.com/PRNewswire/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Tue, 21 Jan 2020 09:00:00 -0400 A.06822034 A.25657929 WIZP WIZP WIZPD Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögren's Syndrome http://www.streetinsider.com/PRNewswire/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html for the full story. http://www.streetinsider.com/PRNewswire/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Tue, 21 Jan 2020 09:00:00 -0400 A.06822034 A.25657929 WIZP WIZP WIZPD Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögren's Syndrome http://www.streetinsider.com/PRNewswire/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html for the full story. http://www.streetinsider.com/PRNewswire/Wize+Pharma+Completes+Patient+Enrollment+In+Phase+IV+Study+Of+LO2A+for+the+Treatment+of+Dry+Eye+Syndrome+in+Patients+With+Sj%C3%B6gren%27s+Syndrome/16352808.html Tue, 21 Jan 2020 09:00:00 -0400 A.06822034 A.25657929 WIZP WIZP WIZPD LO2A Licensor, Resdevco, Granted Market Approval for the Treatment of Sjögren's Syndrome in Hungary http://www.streetinsider.com/Press+Releases/LO2A+Licensor%2C+Resdevco%2C+Granted+Market+Approval+for+the+Treatment+of+Sj%C3%B6gren%27s+Syndrome+in+Hungary/15241674.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/LO2A+Licensor%2C+Resdevco%2C+Granted+Market+Approval+for+the+Treatment+of+Sj%C3%B6gren%27s+Syndrome+in+Hungary/15241674.html for the full story. http://www.streetinsider.com/Press+Releases/LO2A+Licensor%2C+Resdevco%2C+Granted+Market+Approval+for+the+Treatment+of+Sj%C3%B6gren%27s+Syndrome+in+Hungary/15241674.html Mon, 11 Mar 2019 11:07:00 -0400 A.22138756 WIZP WIZPD LO2A Licensor, Resdevco, Granted Market Approval for the Treatment of Sjögren's Syndrome in Hungary http://www.streetinsider.com/Press+Releases/LO2A+Licensor%2C+Resdevco%2C+Granted+Market+Approval+for+the+Treatment+of+Sj%C3%B6gren%27s+Syndrome+in+Hungary/15241674.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/LO2A+Licensor%2C+Resdevco%2C+Granted+Market+Approval+for+the+Treatment+of+Sj%C3%B6gren%27s+Syndrome+in+Hungary/15241674.html for the full story. http://www.streetinsider.com/Press+Releases/LO2A+Licensor%2C+Resdevco%2C+Granted+Market+Approval+for+the+Treatment+of+Sj%C3%B6gren%27s+Syndrome+in+Hungary/15241674.html Mon, 11 Mar 2019 11:07:00 -0400 A.22138756 WIZP WIZPD LO2A Licensor, Resdevco, Granted Market Approval for the Treatment of Sjögren's Syndrome in Hungary http://www.streetinsider.com/Press+Releases/LO2A+Licensor%2C+Resdevco%2C+Granted+Market+Approval+for+the+Treatment+of+Sj%C3%B6gren%27s+Syndrome+in+Hungary/15241674.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/LO2A+Licensor%2C+Resdevco%2C+Granted+Market+Approval+for+the+Treatment+of+Sj%C3%B6gren%27s+Syndrome+in+Hungary/15241674.html for the full story. http://www.streetinsider.com/Press+Releases/LO2A+Licensor%2C+Resdevco%2C+Granted+Market+Approval+for+the+Treatment+of+Sj%C3%B6gren%27s+Syndrome+in+Hungary/15241674.html Mon, 11 Mar 2019 11:07:00 -0400 A.22138756 WIZP WIZPD Wize Pharma, Inc. Announces Publication of Peer Reviewed LOA2 Data on Treatment of Moderately Severe Sjögren's Syndrome-Related Dry Eye http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+Publication+of+Peer+Reviewed+LOA2+Data+on+Treatment+of+Moderately+Severe+Sj%C3%B6gren%27s+Syndrome-Related+Dry+Eye/14996235.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+Publication+of+Peer+Reviewed+LOA2+Data+on+Treatment+of+Moderately+Severe+Sj%C3%B6gren%27s+Syndrome-Related+Dry+Eye/14996235.html for the full story. http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+Publication+of+Peer+Reviewed+LOA2+Data+on+Treatment+of+Moderately+Severe+Sj%C3%B6gren%27s+Syndrome-Related+Dry+Eye/14996235.html Thu, 10 Jan 2019 13:31:00 -0400 WIZP WIZPD Wize Pharma, Inc. Announces Publication of Peer Reviewed LOA2 Data on Treatment of Moderately Severe Sjögren's Syndrome-Related Dry Eye http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+Publication+of+Peer+Reviewed+LOA2+Data+on+Treatment+of+Moderately+Severe+Sj%C3%B6gren%27s+Syndrome-Related+Dry+Eye/14996235.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+Publication+of+Peer+Reviewed+LOA2+Data+on+Treatment+of+Moderately+Severe+Sj%C3%B6gren%27s+Syndrome-Related+Dry+Eye/14996235.html for the full story. http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+Publication+of+Peer+Reviewed+LOA2+Data+on+Treatment+of+Moderately+Severe+Sj%C3%B6gren%27s+Syndrome-Related+Dry+Eye/14996235.html Thu, 10 Jan 2019 13:31:00 -0400 WIZP WIZPD Wize Pharma, Inc. Announces $4.45 Million Private Placement http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+%244.45+Million+Private+Placement/14731647.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+%244.45+Million+Private+Placement/14731647.html for the full story. http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+%244.45+Million+Private+Placement/14731647.html Tue, 23 Oct 2018 08:30:00 -0400 A.09642568 A.19657706 WIZP WIZP WIZPD Wize Pharma, Inc. Announces $4.45 Million Private Placement http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+%244.45+Million+Private+Placement/14731647.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+%244.45+Million+Private+Placement/14731647.html for the full story. http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+%244.45+Million+Private+Placement/14731647.html Tue, 23 Oct 2018 08:30:00 -0400 A.09642568 A.19657706 WIZP WIZP WIZPD Wize Pharma, Inc. Announces $4.45 Million Private Placement http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+%244.45+Million+Private+Placement/14731647.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+%244.45+Million+Private+Placement/14731647.html for the full story. http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+%244.45+Million+Private+Placement/14731647.html Tue, 23 Oct 2018 08:30:00 -0400 A.09642568 A.19657706 WIZP WIZP WIZPD Wize Pharma, Inc. Announces $4.45 Million Private Placement http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+%244.45+Million+Private+Placement/14731647.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+%244.45+Million+Private+Placement/14731647.html for the full story. http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+%244.45+Million+Private+Placement/14731647.html Tue, 23 Oct 2018 08:30:00 -0400 A.09642568 A.19657706 WIZP WIZP WIZPD Wize Pharma, Inc. Announces $4.45 Million Private Placement http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+%244.45+Million+Private+Placement/14731647.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+%244.45+Million+Private+Placement/14731647.html for the full story. http://www.streetinsider.com/Press+Releases/Wize+Pharma%2C+Inc.+Announces+%244.45+Million+Private+Placement/14731647.html Tue, 23 Oct 2018 08:30:00 -0400 A.09642568 A.19657706 WIZP WIZP WIZPD Wize Pharma Appoints Ellen Lubman to its Advisory Board http://www.streetinsider.com/Press+Releases/Wize+Pharma+Appoints+Ellen+Lubman+to+its+Advisory+Board/14600579.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wize+Pharma+Appoints+Ellen+Lubman+to+its+Advisory+Board/14600579.html for the full story. http://www.streetinsider.com/Press+Releases/Wize+Pharma+Appoints+Ellen+Lubman+to+its+Advisory+Board/14600579.html Wed, 12 Sep 2018 10:00:00 -0400 A.12528723 A.28588901 WIZP WIZP WIZPD Wize Pharma Appoints Ellen Lubman to its Advisory Board http://www.streetinsider.com/Press+Releases/Wize+Pharma+Appoints+Ellen+Lubman+to+its+Advisory+Board/14600579.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wize+Pharma+Appoints+Ellen+Lubman+to+its+Advisory+Board/14600579.html for the full story. http://www.streetinsider.com/Press+Releases/Wize+Pharma+Appoints+Ellen+Lubman+to+its+Advisory+Board/14600579.html Wed, 12 Sep 2018 10:00:00 -0400 A.12528723 A.28588901 WIZP WIZP WIZPD Wize Pharma Appoints Ellen Lubman to its Advisory Board http://www.streetinsider.com/Press+Releases/Wize+Pharma+Appoints+Ellen+Lubman+to+its+Advisory+Board/14600579.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wize+Pharma+Appoints+Ellen+Lubman+to+its+Advisory+Board/14600579.html for the full story. http://www.streetinsider.com/Press+Releases/Wize+Pharma+Appoints+Ellen+Lubman+to+its+Advisory+Board/14600579.html Wed, 12 Sep 2018 10:00:00 -0400 A.12528723 A.28588901 WIZP WIZP WIZPD Wize Pharma Appoints Ellen Lubman to its Advisory Board http://www.streetinsider.com/Press+Releases/Wize+Pharma+Appoints+Ellen+Lubman+to+its+Advisory+Board/14600579.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wize+Pharma+Appoints+Ellen+Lubman+to+its+Advisory+Board/14600579.html for the full story. http://www.streetinsider.com/Press+Releases/Wize+Pharma+Appoints+Ellen+Lubman+to+its+Advisory+Board/14600579.html Wed, 12 Sep 2018 10:00:00 -0400 A.12528723 A.28588901 WIZP WIZP WIZPD Wize Pharma Appoints Ellen Lubman to its Advisory Board http://www.streetinsider.com/Press+Releases/Wize+Pharma+Appoints+Ellen+Lubman+to+its+Advisory+Board/14600579.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Wize+Pharma+Appoints+Ellen+Lubman+to+its+Advisory+Board/14600579.html for the full story. http://www.streetinsider.com/Press+Releases/Wize+Pharma+Appoints+Ellen+Lubman+to+its+Advisory+Board/14600579.html Wed, 12 Sep 2018 10:00:00 -0400 A.12528723 A.28588901 WIZP WIZP WIZPD